117 related articles for article (PubMed ID: 11180212)
1. Acute axonal neuropathy in maple syrup urine disease.
Kleopa KA; Raizen DM; Friedrich CA; Brown MJ; Bird SJ
Muscle Nerve; 2001 Feb; 24(2):284-7. PubMed ID: 11180212
[TBL] [Abstract][Full Text] [Related]
2. Sensory-motor polyneuropathy occurring in variant maple syrup urine disease.
Harty S; King MD; McCoy B; Costigan D; Treacy EP
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S209-11. PubMed ID: 18855118
[TBL] [Abstract][Full Text] [Related]
3. Successful pregnancy in maple syrup urine disease: a case report and review of the literature.
Grünert SC; Rosenbaum-Fabian S; Schumann A; Schwab KO; Mingirulli N; Spiekerkoetter U
Nutr J; 2018 May; 17(1):51. PubMed ID: 29753318
[TBL] [Abstract][Full Text] [Related]
4. Acute Pancreatitis in a Patient with Maple Syrup Urine Disease: A Management Paradox.
Gold NB; Blumenthal JA; Wessel AE; Stein DR; Scott A; Fox VL; Turner A; Kritzer A; Rajabi F; Peeler K; Tan WH
J Pediatr; 2018 Jul; 198():313-316. PubMed ID: 29681447
[TBL] [Abstract][Full Text] [Related]
5. Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after Campylobacter infection.
Ho TW; Hsieh ST; Nachamkin I; Willison HJ; Sheikh K; Kiehlbauch J; Flanigan K; McArthur JC; Cornblath DR; McKhann GM; Griffin JW
Neurology; 1997 Mar; 48(3):717-24. PubMed ID: 9065554
[TBL] [Abstract][Full Text] [Related]
6. Acute motor and sensory axonal neuropathy (AMSAN) in a 15-year-old boy presenting with severe pain and distal muscle weakness.
Rostásy KM; Huppke P; Beckers B; Brockmann K; Degenhardt V; Wesche B; König F; Gärtner J
Neuropediatrics; 2005 Aug; 36(4):260-4. PubMed ID: 16138251
[TBL] [Abstract][Full Text] [Related]
7. Perineuritis in acute lyme neuroborreliosis.
Elamin M; Alderazi Y; Mullins G; Farrell MA; O'Connell S; Counihan TJ
Muscle Nerve; 2009 Jun; 39(6):851-4. PubMed ID: 19441045
[TBL] [Abstract][Full Text] [Related]
8. Acute nutritional axonal neuropathy.
Hamel J; Logigian EL
Muscle Nerve; 2018 Jan; 57(1):33-39. PubMed ID: 28556429
[TBL] [Abstract][Full Text] [Related]
9. Is demyelination a feature of maple syrup urine disease?
Müller K; Kahn T; Wendel U
Pediatr Neurol; 1993; 9(5):375-82. PubMed ID: 8292212
[TBL] [Abstract][Full Text] [Related]
10. Cerebral Oedema, Blood-Brain Barrier Breakdown and the Decrease in Na(+),K(+)-ATPase Activity in the Cerebral Cortex and Hippocampus are Prevented by Dexamethasone in an Animal Model of Maple Syrup Urine Disease.
Rosa L; Galant LS; Dall'Igna DM; Kolling J; Siebert C; Schuck PF; Ferreira GC; Wyse ATS; Dal-Pizzol F; Scaini G; Streck EL
Mol Neurobiol; 2016 Aug; 53(6):3714-3723. PubMed ID: 26133302
[TBL] [Abstract][Full Text] [Related]
11. Chronic relapsing axonal neuropathy: a first case report.
Chroni E; Hall SM; Hughes RA
Ann Neurol; 1995 Jan; 37(1):112-5. PubMed ID: 7818243
[TBL] [Abstract][Full Text] [Related]
12. Management of a Woman With Maple Syrup Urine Disease During Pregnancy, Delivery, and Lactation.
Wessel AE; Mogensen KM; Rohr F; Erick M; Neilan EG; Chopra S; Levy HL; Gray KJ; Wilkins-Haug L; Berry GT
JPEN J Parenter Enteral Nutr; 2015 Sep; 39(7):875-9. PubMed ID: 24618664
[TBL] [Abstract][Full Text] [Related]
13. Long-term metabolic follow-up and clinical outcome of 35 patients with maple syrup urine disease.
Abi-Wardé MT; Roda C; Arnoux JB; Servais A; Habarou F; Brassier A; Pontoizeau C; Barbier V; Bayart M; Leboeuf V; Chadefaux-Vekemans B; Dubois S; Assoun M; Belloche C; Alili JM; Husson MC; Lesage F; Dupic L; Theuil B; Ottolenghi C; de Lonlay P
J Inherit Metab Dis; 2017 Nov; 40(6):783-792. PubMed ID: 28905140
[TBL] [Abstract][Full Text] [Related]
14. Severe early-onset polyneuropathy in insulin-dependent diabetes mellitus. A clinical and pathological study.
Said G; Goulon-Goeau C; Slama G; Tchobroutsky G
N Engl J Med; 1992 May; 326(19):1257-63. PubMed ID: 1560802
[TBL] [Abstract][Full Text] [Related]
15. Acute illness in maple syrup urine disease: dynamics of protein metabolism and implications for management.
Thompson GN; Francis DE; Halliday D
J Pediatr; 1991 Jul; 119(1 Pt 1):35-41. PubMed ID: 2066856
[TBL] [Abstract][Full Text] [Related]
16. Neuropathy due to podophyllin intoxication.
O'Mahony S; Keohane C; Jacobs J; O'Riordain D; Whelton M
J Neurol; 1990 Apr; 237(2):110-2. PubMed ID: 2162382
[TBL] [Abstract][Full Text] [Related]
17. Successful repair and postoperative management of tetralogy of Fallot in a patient with maple syrup urine disease.
Fukutomi M; Kitamura S; Kawachi K; Tsuji T; Hashimoto K; Yoshioka A
Heart Vessels; 1993; 8(1):48-51. PubMed ID: 8454563
[TBL] [Abstract][Full Text] [Related]
18. Primary human fibroblasts from a maple syrup urine disease patient undergo apoptosis following exposure to physiological concentrations of branched chain amino acids.
Jouvet P; Kozma M; Mehmet H
Ann N Y Acad Sci; 2000; 926():116-21. PubMed ID: 11193026
[TBL] [Abstract][Full Text] [Related]
19. Acute painful neuropathy in thallium poisoning.
Kuo HC; Huang CC; Tsai YT; Chu CC; Hsieh ST; Chu NS
Neurology; 2005 Jul; 65(2):302-4. PubMed ID: 16043805
[TBL] [Abstract][Full Text] [Related]
20. Definition of the mutation responsible for maple syrup urine disease in Poll Shorthorns and genotyping Poll Shorthorns and Poll Herefords for maple syrup urine disease alleles.
Dennis JA; Healy PJ
Res Vet Sci; 1999 Aug; 67(1):1-6. PubMed ID: 10425233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
